Immunotherapy results in TNF-α production and T cell accumulation in tumors, promotes histone methylase EZH2 activity in melanoma, decreases immunogenicity, silences antigen-presentation, and up-regulates PD-L1 expression. The gene discussed is CD274; the disease is melanoma.